goralatide has been researched along with Cardiac Remodeling, Ventricular in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP | 1 |
André, S; Carretero, OA; D'Ambrosio, M; Gabius, HJ; Liao, TD; Liu, YH; Peng, H; Rhaleb, NE; Sharma, U | 1 |
Merali, S; Sherwi, N; Wong, K | 1 |
Caers, J; Vanderkerken, K | 1 |
Cavasin, MA | 1 |
2 review(s) available for goralatide and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Personalizing biomarker strategies in heart failure with galectin-3.
Topics: Biomarkers; Fibrosis; Galectin 3; Heart Failure; Humans; Oligopeptides; Prognosis; Translational Research, Biomedical; Ventricular Remodeling | 2012 |
Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
Topics: Animals; Heart; Humans; Models, Biological; Myocardial Infarction; Myocardium; Oligopeptides; Thymosin; Ventricular Remodeling | 2006 |
3 other study(ies) available for goralatide and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling | 2014 |
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Body Weight; Cardiac Output; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Models, Animal; Echocardiography, Doppler; Fibrosis; Galectin 3; Heart Rate; Hemodynamics; Inflammation; Infusions, Parenteral; Isoproterenol; Macrophages; Male; Mast Cells; Myocardial Contraction; Myocardium; Oligopeptides; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Stroke Volume; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Ac-SDKP: linking cardiac remodeling to hematological malignancies.
Topics: Animals; Growth Inhibitors; Hematologic Neoplasms; Humans; Neovascularization, Pathologic; Oligopeptides; Ventricular Remodeling | 2006 |